Avandia, manufactured by GlaxoSmithKline, has been linked to congestive heart failure, heart attacks, strokes and other serious side effects. The FDA has urged the manufacture to strengthen warnings of potential weight gain, shortness of breath, and edema which lead to heart failure.
November 16, 2012 — 38 states will split a $90 million settlement with GlaxoSmithKline over marketing of Avandia. Click here to read more.
July 2012 –– GlaxoSmithKline will pay $3 billion to the federal U.S. government for minimizing links between Avandia and heart attack, stroke, and death.
What is the problem with Avandia?
Avandia is a popular drug used to treat Type-2 Diabetes Mellitus that was approved by the FDA in 1999. Over 6 million diabetic patients around the world have used Avandia. After many adverse event reports of heart failure, the FDA has urged GlaxoSmithKline to update their labels to warn of this risk. Studies have shown that Avandia doubles to risk of heart failure leading to a 42% raised risk of heart attacks.
Side Effects of Avandia
There are a variety of side effects associated with Avandia. Our firm is pursing the following types of serious, life-threatening side effects:
- Heart Attack
- Congestive Heart Failure
- Weight Gain
- Macular Edema
- Bone Fractures
- Shortness of Breath